NIFTY 50

Sun Pharma to acquire Japan’s Pola Pharma for $1 million

Updated : November 27, 2018 12:25 PM IST

The company has entered into a definitive agreement to acquire Pola Pharma, which is engaged in research and development, manufacture, sale and distribution of branded and generic products in Japan, Sun Pharmaceutical Industries said in a statement.
Pola Pharma’s portfolio mainly comprises dermatology products. It has two manufacturing facilities in Saitama with capabilities to manufacture topical products and injectables.

You May Also Like

Live TV

recommended for you